Identification of human T-lymphotropic virus type I (HTLV-I) subtypes using restrited fragment length polymorphism in a cohort of asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from São Paulo, Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 97, Issue 3, 2002, Pages 329-333

  Segurado, Aluisio A C ^a   Biasutti, Claudia ^a   Zeigler, Rogério ^a   Rodrigues, Cristhieni ^a   Damas, Cristine D ^a   Jorge, Maria Lúcia S G ^a   Marchiori, Paulo E ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brazil; HTLV I; Restricted fragment length polymorphism; S o Paulo; Subtype

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; COHORT ANALYSIS; FEMALE; GENETICS; HETEROZYGOTE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPASTIC PARAPLEGIA; VIROLOGY;

ADOLESCENT; ADULT; AGED; BRAZIL; CARRIER STATE; COHORT STUDIES; DNA, VIRAL; FEMALE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; MALE; MIDDLE AGED; PARAPARESIS, TROPICAL SPASTIC; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0036547929     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762002000300009     Document Type: Article

References (37)

1. Araújo AQ-C, Andrade-Filho AS, Castro-Costa M, Menna-Barreto M, Almeida SM 1999. HTLV-I-associated myelopathy/tropical spastic paraparesis in Brazil: a nationwide survey. HAM/TSP Brazilian Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 19: 536-541.
2. Bellei NCJ, Granato CFH, Tomiyiama H, Castelo A, Ferreira Jr O 1996. HTLV infection in a group of prostitutes and their male sexual clients in Brazil: seroprevalence and risk factors. Trans R Soc Trop Med Hyg 90: 122-125.
3. Canavaggio M, Leckie G, Allain JP, Steaffens JW, Laurian Y, Brettler D, Lee H 1990. The prevalence of antibody to HTLV-I/II in United States plasma donors and in United States and French hemophiliacs. Transfusion 30: 780-782.
4. Casseb JSR, Caterino-de Araújo A, Hong MA, Salornão M. Gallo D, Hendry RM, Duarte AJS 1997. Prevalence of HTLV-I and HTLV-II infections among HIV-I-infected asymptomatic individuals in São Paulo, Brazil. Rev Inst Med Trop São Paulo 39: 213-215.
5. Castro LHM, Chaves CJ, Callegaro D, Nóbrega JPS, Scaff M 1989. HTLV-I associated myelopathy in Brazil. Arq Neuro-Psiquiatr (SP) 47: 501-502.
6. Cortes E, Detels R, Aboulafia D, Li XL, Moudgil T, Alam M, Bonecker C, Gonzaga A, Oyafuso L, Tondo M, Boite C, Hammershlak N, Capitani C, Slamon DJ, Ho DD 1989. HIV-I, HIV-2 and HTLV-I infection in high-risk groups in Brazil. N Engl J Med 320: 953-958.
7. Dourado I, Andrade T, Galvào-Castro B 1998. HTLV-I in Northeast Brazil: differences for male and female injecting drug users. J Acquir Immune Defic Syndr Hum Retrovirol 19: 426-429.
8. Ferreira Junior OC, Vaz RS, Carvalho MB, Guerra C, Fabron AL, Rosemblit J, Hamerschlak N 1995. Human T-lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from São Paulo, Brazil. Transfusion 35: 258-263.
9. Galvão-Castro B, Loures L, Rodrigues LGM, Sercno A, Ferreira Jr O, Franco LGP, Muller M. Sampaio DA, Santana A, Passos LM, Proietti F 1997. Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study. Transfusion 37: 242.
10. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Callender A, De Thé G 1985. Antibodies to human T-cell lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet 2: 470-410.
11. Komurian-Pradel F, Pelloquin F, Sonoda S, Osamc M, De Thé G 1992. Geographical subtypes demonstrated by RFLP following PCR in the LTR region of HTLV-I. AIDS Res Hum Retroviruses 8: 429-434.
12. La Grenade L, Hanchard B, Fletcher V, Cranston B, Blattner W 1990. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 336: 1345-1347.
13. Mahieux R, Ibrahim F, Mauclère P, Herve V, Michel P, Tekaia F, Chappey C, Garin B, Van Der Ryst E, Guillemain B, Ledru E, Delaporte E, De Thé G, Gessain A 1997. Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-I molecular subtype in Central Africa and in pygmies. J Virol 71: 1317-1333.
14. Mariette X, Cherot P, Cazals D, Boucheriou D, Brouet J, Agbalika F 1995. Antibodies to HTLV-I in Sjögren's syndrome. Lancet 345: 71.
15. Miura T, Fukunaga T, Igarashi T, Yamashita M, Ido E, Funahashi S, Ishida T, Washio K, Ueda S, Hashimoto K, Yoshida M, Osame M, Singhal BS, Zaninovic V. Cartier L, Sonoda S, Tajima K, Ina Y, Gojobori T, Hayami M 1994. Phylogenetic subtypes of human T-lymphotropic virus type I and their relation to the anthropological background. Proc Natl Acad Sci USA 91: 1124-1127.
16. Mochtzuki M, Tajima K, Watanabe T, Yamaguchi K 1994. Human T lymphotropic virus type I uveitis. Br J Ophtalmol 78: 149-154.
17. Morgan OS, Rodgers-Johnson P, Mora C, Char G 1989. HTLV-1 and polymyositis in Jamaica. Lancet 2: 1184.
18. Morofuji-Hirata M, Kajiyama W, Nakashima K, Noguchi A, Hayashi J, Kashiwagi S 1993. Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years. Am J Epidemiol 137: 43-48.
19. Murphy FA 1996. Viral taxonomy. In BN Fields, DM Knipe, PM Hailey, RM Chavock, JL Melack, TP Monath, B Roizman, SE Strauss (eds), Fundamental Virology, Lippincott Raven, Philadelphia, p. 15-57.
20. Nishioka K, Maruyama I, Sato K, Kitajima Y, Osame M 1989. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1: 441-442.
21. Oliveira MSP, Matutes E. Famadas LC, Schulz TF, Calabró ML, Nucci M, Andrada-Serpa MJ, Tedder RS, Weiss RA, Catovsky D 1990. Adult T-cell leukemia/lymphoma in Brazil and its relation to HTLV-I. Lancet 336: 987-990.
22. Osame M, Usuku K., Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet 1: 1031-1032.
23. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC 1980. Detection and isolation of type C retrovirus particles from fresh and culture lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 77: 7415-7419.
24. Ratner L, Philpott T, Trowbridge DB 1991. Nucleotide sequence analysis of isolates of human T-lymphotropic virus type I of diverse geographical origins. AIDS Res Hum Retroviruses 7: 923-941.
25. Schulz TF, Calabró ML, Hoad JG, Carrington CVF, Matutes E, Catovsky D, Weiss RA 1991. HTLV-I envelope sequences from Brazil, the Caribbean and Rumania: clustering according to geographical origin and variability in an antibody cpitope. Virology 184: 483-491.
26. Segurado AAC, Granade T, Parekh B, Nunez CA, Meza R, Amador L, Terrell S, George JR, Lal RB 1997a. Presence of human T-cell lymphotropic virus types I and II infection in Honduras. J AIDS Hum Retrovirol 16: 308.
27. Segurado AAC, Malaque CMS, Sumita LM, Pannuti CS, Lal RB 1997b. Laboratory characterization of human T-cell lymphotropic virus types I (HTLV-I) and II (HTLV-II) infections in blood donors from São Paulo, Brazil. Am J Trop Med Hyg 57: 142-148.
28. Takatsuki K, Yamaguchi K, Kawano F, Hattori T, Nishimura H, Tsuda H, Sanada I, Nakada K, Itai Y 1985. Clinical diversity in adult T-cell leukemia lymphoma. Cancer Res 45 (Suppl.): 4644-4645s.
29. Trujillo JM, Concha M, Munoz A, Bergonzolli G, Mora C, Borrero I, Gibbs Jr CJ, Arango C 1992. Seroprevalence and cofactors of HTLV-I infection in Tumaco, Colombia. AIDS Res Hum Retroviruses 5: 651-657.
30. Tuke PW, Luton P, Garson JA 1992. Differential diagnosis of HTLV-I and HTLV-II infections by restriction enzyme analysis of "nested" PCR products. J Virol Meth 40: 163-174.
31. Ureta-Vidai A, Gessain A, Tekaia F, Garin B, Guillemain B, Schulz T, Farid E, De Thé G 1994. Phylogenetic classification of human T-cell leukemia/lymphoma virus type I genotypes in five major molecular and geographical subtypes. J Gen Virol 75: 3655-3666.
32. Wattel E, Mariotti M, Agis F, Gordien E, Prou O, Courouce AM, Rouger P, Wain-Hobson S, Chen ISY, Lefrere JJ 1992. Human T lymphotropic virus (HTLV) type I and II DNA amplification in HTLV-I/II-seropositive blood donors of the French West Indies. J Infect Dis 165: 369-372.
33. WHO-World Health Organization 1989. Report of the scientific group on HTLV-I and diseases, Kagoshima, Japan, December, 1988. Virus Diseases, Human T-lymphotropic virus type I, HTLV-I. Wkly Epideml Rec 64: 382-383.
34. WHO-World Health Organization 1990. Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2 and HTLV-I/II. Wkly Epidern Rec 65: 281-283.
35. Yamashita M, Ido E, Miura T, Hayami M 1996. Molecular epidemiology of HTLV-I in the world. J Acquir Immune Defic Syndr Hum Retrovirol 13 (Suppl. I): S124-131.
36. Yamashita M, Veronesi R, Menna-Barreto M, Harrington Jr W, Sampaio C, Brites C, Badarȯ R, Andrade-Filho AS, Ohkura S, Igarashi T, Takehisa J, Miura T, Chamone D, Bianchini O, Jardim C, Sonoda S, Hayami M 1999. Molecular epidemiology of human T-cell leukemia virus type I (HTLV-I) in Brazil: the predominant HTLV-Is in South America differ from HTLV-Is of Japan and Africa, as well as those of those of Japanese immigrants and their relatives in Brazil. Virology 261: 59-69.
37. Yanagihara R, Garruto RM, Miller MA, Leon-Monzon M, Liberski PP, Gajdusek DC, Jenkins CL, Sanders RC. Alpers MP 1990. Isolation of HTLV-I from members of a remote tribe in New Guinea. N Engl J Med 323: 993-994.